CONFIDENTIAL TMF-16134662 The GSK group of companies BEL114256 1 TITLE PAGE Division: Worldwide Development Information Type: Worldwide Epidemiology Final Study Report Title: Belimumab (BENLYSTA) Pregnancy Registry (BEL114256) Final Analysis Report Compound
…
18-Jul-2022 Current Protocol Date (2.0): 1 3 -F e b -2 0 2 3
…
Spravodajská jednotka doručí výkaz do 10. kalendárneho dňa po sledovanom období 1 x Národnému centru zdravotníckych informácií Lazaretská 26 811 09 Bratislava neukončené Vážený respondent, Ministerstvo zdravotníctva SR vykonáva štatistické zisťovanie za
…
Approved Product: Prolia® (denosumab) Protocol Number: 20110132 Date: 28 February 2012 Page 1 of 37 Title: Prospective Observational Study to Describe Characteristics and Management of Patients With Postmenopausal Osteoporosis Treated With Prolia® in Routine
…
Clinical Development FTY720D (Fingolimod) Study protocol CFTY720D2406 Long-term, prospective, non-interventional, multinational, parallel-cohort study monitoring safety in patients with MS recently initiated with fingolimod once daily or treated with another
…
1. ABSTRACT Title Title: Prospective Observational Study to evaluate the persistence of treatment with XGEVA® in patients with bone metastases from solid tumors for prevention of skeletal related events (SREs) in routine clinical practice Date
…
Inflectra (infliximab) Post-Marketing Observational Study Protocol Number: ZOB INF 1402 Confidential Page 1 of 64 Protocol Information Title Post-Marketing Observational Cohort Study of Patients with Inflammatory Bowel Disease (IBD) Treated with Inflectra
…
0 1 2 1 Odoslané dňa: Podpis vedúceho Výkaz zostavil Telefón (smerové číslo): spravodajskej jednotky: (meno a priezvisko): E-mail: Klapka: Názov okresu Údaje za právnickú osobu Názov spravodajskej jednotky (SJ) -organizácia /poskytovateľ zdravotnej
…